<DOC>
	<DOC>NCT02858245</DOC>
	<brief_summary>A prospective, open-label, and multi-centered feasibility registry.</brief_summary>
	<brief_title>A Feasibility Registry of Actigraphy Monitoring in Degenerative Mitral Regurgitation Subjects Receiving the MitraClipÂ® Device</brief_title>
	<detailed_description>This is a prospective, open-label, and multi-centered feasibility registry (single arm study). Approximately 36 subjects with prohibitive risk degenerative mitral regurgitation (DMR) who receive at least 1 commercial MitraClip will be registered at approximately 7 US sites.</detailed_description>
	<mesh_term>Mitral Valve Insufficiency</mesh_term>
	<criteria>Subject must consent to receiving the MitraClip device Subject must consent, be able, and commit to wearing the Actiwatch continuously for approximately 7 months Subject must consent to use of their data from this registry for purposes of exploratory research and publication and presentation Subject is not a member of vulnerable population Subject must not have any disabilities that preclude reliable data collection from the Actiwatch, e.g., epilepsy with uncontrolled recurring episodes, serious stage degenerative/disabling disease (e.g. Parkinson's disease), inability to walk or will require walking aids, etc.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>